SHARLA F. FLOHR, PH.D.
Sharla Flohr is a patent agent who works with clients in the biotechnology, chemistry, and pharmaceutical fields to protect their valuable inventions by obtaining strong patent portfolios. Sharla believes in the importance of evaluating each invention to ensure patent applications are drafted and prosecuted with the client’s goals in mind.
Prior to joining the firm, Sharla worked for eight years as a patent agent at Human Genome Sciences, Inc. where she regularly evaluated the company’s ongoing research and development for patentability and developed strategies for protecting their pipeline candidates. In particular, Sharla was in charge of managing the patent portfolio for HGS’s commercial product, BENLYSTA®. In this role, she identified possibilities for maximizing patent term, oversaw the prosecution of U.S. and foreign patents, prepared and filed applications for U.S. Patent Term Extension and European Supplementary Protection Certificates, and participated in district court litigation.
Sharla was awarded a competitive Pharmacology Research Associate Training Fellowship grant to support her postdoctoral research at the National Institutes of Health in the endocrinology field studying receptor regulation in response to stress.
Sharla has two active children and spends much of her free time travelling to various practices and games. Thus, she is highly skilled at time management and juggling multiple tasks at once.
- Wake Forest University School of Medicine, Ph.D. Physiology
- Virginia Tech, B.S. Animal Sciences
- United States Patent & Trademark Office, 2007